FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2024
Back to search
Official data from USPTO
NANOENTEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
11/30/2024
Classification
Registered
Trademark type
Combined
Nice classes
10
Filing date
05/11/2022
Registration date
05/21/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
05/21/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists of the stylized wording "NANOENTEK", with "NANO" in grey and "ENTEK" in green. To the left of the wording is an image of two touching squares, the top being green with a white interior, and the bottom being grey.".
Holders and representatives
Holders
NANOENTEK, INC.
Representatives
Sangwon Kim Revolution IP, PLLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Flow-based analyzers providing particle and cell size analysis for medical purposes; flow cytometers for medical diagnosis; electroporators for biomolecules or drugs for medical purposes; flow-based analyzers providing automated cell counting for medical purposes; medical apparatus for automatic diagnosis of tuberculosis; urinalysis apparatus and instrumentsfluorescence immunoassay analyzer for analyzing the protein in urine; immune affinity gas chromatography apparatus for medical use; capillary reagent tubes for medical use; medical diagnostic testing apparatus for testing for bacteria and viruses; medical diagnostic apparatus for testing cells for bloodserumplasmacellmoleculeprotein levels; medical instruments for measuring bloodserumplasmacellmoleculeprotein levels for cancer diagnosis; medical devicesminiaturized sensors for gathering data in connection with gene analysis and diagnosis; immunochemical testing apparatus for medical diagnosis; apparatus for DNA and RNA testing for medical purposes; DNA extraction and purification apparatus for medical purposes; test equipment for medical usecell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; medical immunoassay chemical testing apparatus; immunofluorescence analysis apparatus for testing bloodserumplasmacellmoleculeprotein medical purposes; apparatus for use in medical analysiscell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; real-time gene amplification equipment for medical use; medical genetic analyzer; body fluid analysis apparatus for medical purposes; bloodserumplasmacellmoleculeprotein measuring devices for medical use; fluorescent nanoparticle immunoassay designed for in vitro quantitative measurement cartridges for medical purposes; medical absorption analysis apparatuscell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; apparatus for blood tests for medical use; apparatus for blood analysis for medical use; blood analysis apparatus for diagnosis; diagnostic apparatus and instruments for medical purposescell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; urine analysis devices for medical diagnosisfluorescence immunoassay analyzer for analyzing the protein in urine; clinical-chemical auto analysis apparatus for medical diagnosiscell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; medical apparatus and instruments in the fields of clinical diagnosiscell counterlive cell imager fluorescence immunoassay analyzer and associated test tool; medical diagnostic apparatuscell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool; apparatus for use in medical analysiscell counterlive cell imagerfluorescence immunoassay analyzer and associated test tool and arterial blood pressure measuring apparatus; in vitro diagnostic devices for medical purposesfluorescence immunoassay analyzer; cholesterol meters; medical instruments for measuring hematocrit; blood cell processing handler being sample pretreatment module; medical apparatus in the nature of hemocytometers; blood cell analysis apparatus; flow-based analyzers providing blood cell counting for medical purposes; blood glucose monitoring apparatus for medical purposes; filters for blood and blood components for medical purposes; blood testing apparatus; plasma separators in the nature of blood filterscentrifuge; apparatus for clinical diagnosis of cancerhormonethyroiddiabetesinfectioncardiac; capillary tubes for blood for medical use; capillary tubes for samples medical use; diagnosticexaminationmonitoring equipmentcell counterlive cell imager fluorescence immunoassay analyzer and associated test tool; instruments for extracting human body fluidsbloodurinesaliva; apparatus for taking blood
Publications
History of USPTO decisions and trademark events.
36 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2024
FIMP
FINAL DISPOSITION PROCESSED
11/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2024
PUBO
PUBLISHED FOR OPPOSITION
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/14/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/10/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/28/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/21/2023
GNFR
FINAL REFUSAL E-MAILED
11/21/2023
CNFR
FINAL REFUSAL WRITTEN
11/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2023
RFNP
REFUSAL PROCESSED BY IB
05/24/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/28/2023
RFRR
REFUSAL PROCESSED BY MPU
04/27/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/09/2023
CNRT
NON-FINAL ACTION WRITTEN
03/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/04/2023
DOCK
ASSIGNED TO EXAMINER
03/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/04/2022
Continuous trademark protection
Get notified about every new filing that threatens NANOENTEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.